Natural History of Human Papillomavirus (HPV) Infections in Mid-Adult Women (WHIM)
NCT01295242 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 409
Last updated 2013-11-19
Summary
The purpose of this study is to determine rates of oral and genital human papillomavirus (HPV) infections, and look at risk factors for HPV infection in healthy mid-adult women.
Conditions
- Papillomavirus Infections
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Rachel L Winer, PhD, MPH · University of Washington
Eligibility
- Min Age
- 30 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-02-28
- Primary Completion
- 2012-08-31
- Completion
- 2012-08-31
Countries
- United States
Study Locations
More Related Trials
-
High and Low Resource Interventions to Promote HPV Vaccines
NCT03824093 ·Status: COMPLETED ·Phase: NA
-
The SPOT-HPV Study
NCT05524025 ·Status: COMPLETED
-
MeFirst: A Tailored Intervention to HPV Vaccine Decision Making
NCT01769560 ·Status: COMPLETED ·Phase: NA
-
A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females
NCT05584332 ·Status: TERMINATED ·Phase: PHASE3
-
Study of FluBHPVE6E7 in HPV-16 Infected Women
NCT04490512 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years
NCT06756269 ·Status: RECRUITING ·Phase: PHASE2
-
The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases
NCT02188004 ·Status: COMPLETED
-
Clinical Study of HPV Therapeutic DNA Vaccine (NWRD08) in Patients With Cervical HPV16 and/or HPV18 Positive
NCT05905354 ·Status: UNKNOWN ·Phase: NA
-
"Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine Uptake
NCT06587243 ·Status: RECRUITING ·Phase: NA
-
Phase II Study of Treatment for HPV16+ ASC-US, ASC-H and LSIL
NCT03911076 ·Status: TERMINATED ·Phase: PHASE2
-
A Pilot Study Comparing the Effectiveness of Campus Intervention to Increase HPV Vaccine Rate Among College Aged Men
NCT02508701 ·Status: TERMINATED ·Phase: NA
-
Investigation Into the Infectivity Levels of Human Papilloma Virus (HPV) in Tonsillar Tissue
NCT02841631 ·Status: UNKNOWN
-
A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males
NCT06465914 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The STOP-HPV Scale Up Study
NCT06831383 ·Status: RECRUITING ·Phase: NA
-
Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination
NCT03501992 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Quadrivalent HPV Vaccine to Prevent Relapses of Genital Warts After Initial Therapeutic Response
NCT03296397 ·Status: UNKNOWN ·Phase: PHASE3
-
AV2 Antiviral Spray Versus Placebo in Human Papillomavirus Cervix Infections
NCT01654822 ·Status: UNKNOWN ·Phase: PHASE2
-
Immunevasion of Human Papillomavirus (HPV) in Vulvar Intraepithelial Neoplasia 2/3 and Anogenital Warts and Efficiency and Mechanisms of Imiquimod Treatment
NCT00941811 ·Status: COMPLETED ·Phase: PHASE2
-
Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia
NCT00788164 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years
NCT06454175 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Carrageenan for the Prevention of Oral HPV Infection
NCT05746988 ·Status: UNKNOWN ·Phase: NA
-
Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections.
NCT04232917 ·Status: RECRUITING ·Phase: PHASE4
-
The Psychosocial and Economic Burden of Genital Warts
NCT01520194 ·Status: COMPLETED
-
Typing of Human Papilloma Virus (HPV) From Female Genital Warts
NCT01192282 ·Status: COMPLETED
-
NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients.
NCT06741150 ·Status: RECRUITING ·Phase: NA